Third trimester nonrecurrent fetal loss is associated with factor V Leiden and prothrombin gene mutations

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 18, Issue 5, 2005, Pages 299-304

  Karateke, Ates ^a   Haliloglu, Berna ^a,b   Gurbuz, Ayse ^a  

^a Zeynep Kamil Women's and Children's Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

Factor V Leiden; Fetal loss; Prothrombin gene mutation

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; FETUS WASTAGE; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; SAMPLE SIZE; THIRD TRIMESTER PREGNANCY;

ABORTION, SPONTANEOUS; ADULT; CASE-CONTROL STUDIES; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; MUTATION; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROTHROMBIN;

EID: 30344445935     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050500381354     Document Type: Article

References (25)

1. Yudkin PL, Wood L, Redman CW. Risk of unexplained stillbirth at different gestational ages. Lancet 1987;1:1192-1194.
2. Samueloff A, Xenakis EM, Berkus MD, Huff, RW, Langer O. Recurrent stillbirth: Significance and characteristics. J Reprod Med 1993;38:883-886.
3. Brenner B, Blumenfeld Z. Thrombophilia and fetal loss. Blood Reviews 1997;11:72-79.
4. Kupferminc M, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
5. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002;101:6-14.
6. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, Fontcuberta J, Makris M, Mariani G, Noteboom W et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-916.
7. Martinelli I, Taioli E, Cetin I, Marinoni, A, Gerosja S, Villa MV, Bozza M, Mannucci PM. Mutations in coagulation factors in women with unexplained fetal loss. N Engl J Med 2000;343:1015-1018.
8. De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: Clinical implications. Semin Thromb Haemost 1998;24:367-379.
9. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cuming AM et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-708.
10. Tormene D, Simioni P, Prandoni P, Luni S, Innella B, Sabbion P, Girolami A. The risk of fetal loss in family members of probands with factor V Leiden mutation. Thromb Haemost 1999;82:1237-1239.
11. Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyak K, Prins MH, Buller HR, van der Meer J. Increased risk for fetal loss in carriers of factor V Leiden mutation. Ann Intern Med 1999;130:9736-9739.
12. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, Scianname N, Pavone G, DiMinno G. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997;77:822-824.
13. Kupferminc MJ, Peri H, Zwang E, Yaron Y, Wolman I, Eldor A. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand 2000;79:963-967.
14. Stirrat GM. Recurrent miscarriage. I. Definition and epidemiology. Lancet 1990;336:673-675.
15. Mandel H, Brenner B, Berant M, Rosenberg N, Lanir N, Jakobs C, Fowler B, Seligsohn U. Coexistence of hereditary homocystinuria and Factor V Leiden-effect on thrombosis. N Eng J Med 1996;334:763-768.
16. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
17. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999;82:6-9.
18. Many A, Elad R, Yaron Y, Eldor A, Lessing JB, Kupferminc MJ. Third trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. Obstet Gynecol 2002;99:684-687.
19. Ozbek U, Tangun Y. Frequency of factor V Leiden (Arg506Gln) in Turkey. Br J Haematol 1997;97:504-505.
20. Rothbart H, Ohel G, Younis J, Lanir N, Brenner B. High prevalence of activated protein C resistance due to factor V Leiden mutation in cases of intrauterine fetal death. J Matern Fetal Med 1999;8:228-230.
21. Rey E, Kahn SR, David M, Shreir I. Thrombophilic disorders and fetal loss: A meta-analysis. Lancet 2003;361:901-908.
22. Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: A meta-analysis. Thromb Haemost 2004;91:700-711.
23. Kitzmiller JL, Benirschke K. Immunofluorescent study of placental bed vessels in preeclampsia. Am J Obstet Gynecol 1964;89:225-232.
24. Fox H. The histopathology of placental insufficiency. J Clin Path 1976;10:1-8.
25. Naeye RL. Placental infarction leading to fetal or neonatal death. Obstet Gynecol 1977;50:583-588.